Skip to main content
26-A-15687-ACC SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS (SGLT2I) POST-TRANS CATHETER AORTIC VALVE IMPLANTATION (TAVI): REAL-WORLD SURVIVAL BENEFITS ACROSS THE HEART FAILURE (HF) SPECTRUM · Hikma Research